Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatine LP in Diffuse Hyperinsulinism
NCT00987168Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2009
- Primary completion
- Apr 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of octreotide in congenital hyperinsulinism (HI), sponsored by Assistance publique - Hôpitaux de Paris. Started May 2009; status: completed.
02
Drugs
octreotide
03
Conditions
congenital hyperinsulinism (HI)
Beyond the preview
Go deeper on NCT00987168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00987168.